Clinical & Pharma

The arduous journey from a promising scientific discovery to an approved medical treatment is fraught with financial peril, particularly for rare inherited conditions where market incentives are often misaligned with patient needs. Charcot-Marie-Tooth disease Type 1A (CMT1A), the most common form

A silent and pervasive threat is contaminating global water systems as pharmaceuticals, designed to be stable within the human body, prove to be equally resilient in the environment. Compounds like the antiepileptic drug carbamazepine are continuously released into waterways, bypassing conventional

The journey for a promising new drug from laboratory discovery to a patient's bedside can often span two decades, a timeline that represents a significant barrier to advancing public health and treating critical illnesses. This protracted and costly process is a widely acknowledged bottleneck in

The relentless progression of chronic cholestatic liver diseases, such as primary biliary cholangitis (PBC) and primary sclerosing cholangitis (PSC), presents a daunting challenge in modern medicine, where effective disease-modifying therapies remain frustratingly out of reach. For countless

Health authorities in Bangladesh have officially confirmed a local outbreak of the Zika virus, with ten laboratory-confirmed cases identified in and around the capital city of Dhaka between September and December 2024, providing conclusive evidence of domestic transmission and raising significant

Across Brevard County, a series of strategic enhancements in key community sectors are quietly reshaping the landscape of local support, from empowering individuals with disabilities to pioneering new frontiers in medical research and personal wellness. These developments, driven by dedicated